Taken together, our in vitro and in vivo results show that digitoflavone induced Nrf2-dependent anti-oxidative effects that modulated inflammation in STZ-induced diabetic nephropathy, leading to down-regulation of inflammatory genes and reduced inflammatory cell infiltration. Here, NFE2L2 is linked to diabetic kidney disease.